Share Board Media

Select Where You Want To Share:

Go Ahead and Share This Blog and Watch The Views Soar!
Shared Blogs Receive 98% More Views!

Chelsea Therapeutics (CHTP) FDA Advisory Panel Recommendation Could Change Its Trading Levels

https://www.storeboard.com/blogs/business/chelsea-therapeutics-chtp-fda-advisory-panel-recommendation-could-change-its-trading-levels/257060

Copy

Chelsea Therapeutics International, Ltd. (CHTP) reported that the FDA Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 16-1 to recommend approval of NORTHERA(TM) (droxidopa) for the treatment of symptomatic neurogenic orthostatic hypotension

Click Here To View This Blog